
Warner, Senate colleagues call for diversity in COVID-19 pharmaceutical trials
U.S. Sen. Mark Warner joined a group of Senate colleagues in urging pharmaceutical companies engaged in COVID-19-related work to prioritize diversity in any coronavirus vaccine or trial.




